Mounjaro 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F37K6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,444
Award facts
- Contract value 100% obligated
- $1,444.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pens with a ceiling value of $1,444.28. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The order is scheduled for completion by November 5, 2025, with fulfillment performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Mounjaro is a diabetes medication used for glycemic control, consistent with AmerisourceBergen's extensive pharmaceutical distribution portfolio supporting military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), a comprehensive global pharmaceutical prime vendor contract valued at $999,999,999 and extending through December 2026. The IDC serves as the contracting vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen regularly fulfills competitively awarded delivery orders for specialty medications, brand-name and generic drugs, vaccines, and associated medical supplies across multiple therapeutic domains supporting military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26F37K6?
SPE2DR26F37K6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26F37K6 worth?
The government has obligated $1,444 on SPE2DR26F37K6.
Is contract SPE2DR26F37K6 an order under another contract?
Yes. SPE2DR26F37K6 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F37K6 competed?
The extent of competition for SPE2DR26F37K6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award